NCT Number: NCT00369083
Hospitalization at Home of Elderly Patients With Exacerbated COPD
Aim of the study was to evaluate the efficacy of hospital-at-home treatment compared with inpatient care in selected elderly patients with acute exacerbation of chronic obstructive pulmonary disease (COPD).
Looking for future studies?
Notify MeKey information
Conditions
Age range
75 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
A total of 104 patients with an exacerbation of chronic obstructive pulmonary disease (COPD) selected from the Emergency Department (ED) of the hospital were randomized to home treatment from a Geriatric Home Hospitalization Service (GHHS) or to General Medical Ward (GMW).
The sample size estimation was performed according to the increasing 1-year (June 2002-May 2003) incidence of COPD exacerbation in hospital at home. On this basis, al least 100 patients needed to be included in the study to allow to detect a 20% difference in the endpoint hospital iatrogenic diseases, with a statistical significance = 0.05 and a power 1- = 0.8 using a two-sided test.
This study is considered a single-blind study because patients were aware of the treatment assignment while physicians and nurses evaluating patients were blinded to the patient's allocation.
In the ED all patients underwent baseline standard clinical evaluation; blood tests (blood cell count, routine biochemical tests and arterial blood gas tensions); pulse oximetry; 12-lead electrocardiography; chest radiographs and hand-held spirometry (SpirHOMEter, COSMED, Italy). Further investigations (including pneumologist's assessment) were performed when required, according to the clinical judgement of the ED physician. Only patients with a COPD exacerbation evaluated in ED for at least 12-24 hours and with stable clinical conditions were considered elegible to be included in the study.
Additional exclusion criteria were: 1) living outside the hospital catchment area; 2) absence of family and social support; 3) absence of informed consent; 4) necessity of intensive monitoring or mechanical ventilation; 5) history of dementia; 6) severe renal or hepatic failure; 7) cancer.
Patients fullfilling inclusion criteria were informed about the nature of the study and asked to give their informed consent. Extensive information was also provided to patients' relatives to obtain their collaboration. Patients fullfilling the inclusion criteria and having none of the criteria for exclusion were randomised, using a set of computer-generated random numbers, in a 1:1 ratio either to the treatment group (home-based hospitalization (GHHS)) or to the control group (conventional care (GMW)), using blinded sealed envelopes. Intention-to-treat analysis was used.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Exacerbation of COPD
- Age >= 75 years
- Living in hospital catchment area
- Informed consent
- Adequate social or familial support
Exclusion criteria
- Patients requiring assisted ventilation or intensive monitoring
- History of dementia
- Severe renal or hepatic failure
- Cancer
Treatment and study plan
Primary outcomes
-
Mortality
-
Hospital readmissions at six months
Secondary outcomes
-
Length of hospital admission
-
Caregiver stress
-
Costs
-
Patient's quality of life
Sponsors and collaborators
Lead sponsor
Azienda Ospedaliera San Giovanni Battista
Other
Registry information
Official study title
Home Hospitalizationfor Elderly Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Randomized Controlled Trial.
Important dates
- Study start
- 2004
- Study completion
- 2005
- First posted
- Aug 29, 2006
- Registry last updated
- Aug 29, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Comparison of Multiple Oxygenation Targets With Different Oximeters in Chronic Obstructive Pulmonary Disease (COPD) and Non-COPD Patients- Impact on Oxygen Flows
NCT05819164
COPD Exacerbation, Hypoxemia
Québec, Quebec, Canada
View Trial DetailsA Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD
NCT04320342
COPD, COPD Exacerbation
Birmingham, Alabama, United States
View Trial DetailsEosinophil-guided Reduction of Inhaled Corticosteroids
NCT04481555
Azithromycin, COPD
Aarhus, Denmark
View Trial DetailsPulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation?
NCT05492149
COPD, COPD Exacerbation
Montivilliers, Groupe Hospitalier Du Havre, France
View Trial Details